Exponent (EXPO)
(Delayed Data from NSDQ)
$103.85 USD
-0.20 (-0.19%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $103.80 -0.05 (-0.05%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Price, Consensus and EPS Surprise
EXPO 103.85 -0.20(-0.19%)
Will EXPO be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for EXPO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for EXPO
Is Exponent (EXPO) Outperforming Other Business Services Stocks This Year?
Are Business Services Stocks Lagging Exponent (EXPO) This Year?
EXPO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Exponent (EXPO) Just Flashed Golden Cross Signal: Do You Buy?
Is HNI (HNI) Stock Outpacing Its Business Services Peers This Year?
Why Exponent (EXPO) Might be Well Poised for a Surge
Other News for EXPO
Exponent to Announce Second Quarter of Fiscal Year 2024 Results and Host Quarterly Conference Call on July 25, 2024
TimesSquare Capital U.S. Small/Mid Cap Growth Q1 2024 Commentary
Dividend Champion, Contender, And Challenger Highlights: Week Of June 16
Dividend Champion, Contender, And Challenger Highlights: Week Of June 2
Conestoga Capital Advisors Q1 2024 Commentary